GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biora Therapeutics Inc (FRA:4ZU) » Definitions » Other Income (Expense)

Biora Therapeutics (FRA:4ZU) Other Income (Expense) : €30.15 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biora Therapeutics Other Income (Expense)?

Biora Therapeutics's other income expense for the Biora Therapeutics's pretax income for the three months ended in Sep. 2024 was €-3.62 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was €30.15 Mil.

Biora Therapeutics Other Income (Expense) Historical Data

The historical data trend for Biora Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biora Therapeutics Other Income (Expense) Chart

Biora Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial - -20.62 -42.63 22.20 -43.53

Biora Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.54 -0.50 13.00 21.27 -3.62

Biora Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €30.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biora Therapeutics  (FRA:4ZU) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Biora Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biora Therapeutics Inc (FRA:4ZU) » Definitions » Other Income (Expense)
Comparable Companies
AXIM ISCO EVFM BPTH LADX BTAX ARTH SCPX NBIO TNFA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
4330 La Jolla Village Drive, Suite 300, San Diego, CA, USA, 92122
Website
https://www.bioratherapeutics.com
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Biora Therapeutics Headlines

No Headlines